So many people are now taking medication that the inexorable rise in obesity could start to reverse, one of the biggest ...

Explore how inhibiting myostatin can promote muscle mass in men, addressing sarcopenia, GLP-1 medication effects, and aging ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Everything you need to know about using Ozempic, Wegovy, and Mounjaro to shed those extra pounds. We dive into their perks, ...

PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

For the past two years, Ozempic and Wegovy have dominated the conversation when it comes to weight-loss medications (WLMs). The two medications, developed and distributed by Novo Nordisk, have made ...

Weight-loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medications as alternatives to the traditional — and often ineffective — advice ...

According to the study, participants taking Zepbound lost an average of 20.2% of their starting weight after 72 weeks, compared to a 13.7% loss for those on Wegovy, which Lilly billed as proof ...